Type 2 Diabetes

Calcium Transport Impairment Affects Some Drugs' Platelet Impact

Published in Blood Weekly, October 4th, 2001

by Michael Greer, senior medical writer - Pharmacological factors that affect calcium transport have different effects on platelet activity in type 2 diabetics than they do in other patients, researchers in Poland found.

"Thrombospondin (TSP), which is secreted from a-granules of activated platelets, binds to its surface receptor (CD36) in the presence of Ca²⁺," explained Prof. Cezary Watala and colleagues at the Medical University of Lodz.

Drugs that inhibit or promote calcium transport affect diabetics differently than other patients due to their abnormal calcium ion activity, Watala and coauthors found.

Under normal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-10-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry